Ndonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 6 | 2 | 45 | 88 | 122 |
| Cost of Goods | 3 | 1 | N/A | 4 | 5 |
| Gross Profit | 3 | 1 | 45 | 84 | 117 |
| Operating Expenses | 792 | 474 | 1,177 | 617 | 605 |
| Operating Income | -786 | -473 | -1,131 | -529 | -483 |
| Interest Expense | 374 | 286 | 313 | 309 | 309 |
| Other Income | -443 | -8 | 3,508 | 8,069 | -12,140 |
| Pre-tax Income | -1,603 | -766 | 2,064 | 7,231 | -12,932 |
| Net Income Continuous | -1,603 | -766 | 2,064 | 7,231 | -12,932 |
| Net Income | $-1,603 | $-766 | $2,064 | $7,231 | $-12,932 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | 0.03 | -0.08 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | 0.01 | 0.03 | -0.08 |
| EPS Diluted Total Ops | 0.02 | 0.00 | -0.01 | 0.00 | -0.08 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.08 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.00 | -0.01 | N/A | N/A |
| EBITDA(a) | $-596 | $-314 | $-959 | $-364 | $-301 |